DANI PREST: Open Payments
NPI 1467905299 · BELLE CHASSE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 11 payments from 6 companies in 2025. Trend: 2023 $128 · 2024 $349 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $157 |
| ACADIA Pharmaceuticals Inc | 1 | $110 |
| Alpha Cognition USA, Inc. | 3 | $99 |
| Neurocrine BioSciences, Inc. | 1 | $48 |
| UCB, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: REXULTI, NUPLAZID, Zunveyl, INGREZZA, Fintepla, AUSTEDO XR.
Industry payments across LA — which companies pay providers there.
